3 Things You Need to Know if You Buy Teva Pharmaceutical Stock Today

Group 1 - Teva Pharmaceutical focuses on producing generic drugs, which allows it to benefit from revenue streams when patent protections on original drugs expire [2][3] - The company holds a 35% market share in its home market of Israel, indicating a highly competitive environment in the generics sector [4] - Teva is attempting to differentiate itself by producing harder-to-make generic drugs, which aligns with its technological strengths and aims to protect its profit margins [5][6] Group 2 - The shift towards more complex generic drugs, including biosimilars, introduces additional regulatory challenges and risks, but is seen as a strategy for long-term growth [6][7]